What is CYP2C19?
The CYP2C19 gene contains the instructions for producing an essential liver enzyme that plays a key role in processing various groups of medications. While some enzymes are used broadly, CYP2C19 is of critical importance for the conversion and activation of specific agents, such as certain blood thinners and proton pump inhibitors. Unlike temporary blood values, your CYP2C19 status is genetically fixed; this DNA profile remains the same throughout your entire life.
The gene determines whether your body processes medication at the intended speed. If this pace deviates, it has direct consequences for the effectiveness of your therapy and the risk of unwanted side effects.
Why test your CYP2C19 status?
When the activity of the CYP2C19 enzyme is not optimal, a standard dose can lead to unpredictable results for you:
- Treatment Failure (Prodrugs): Some medications, such as the blood thinner clopidogrel, are not yet active when taken. They must be ‘converted’ by CYP2C19 to work. If the enzyme activity is slow, this conversion does not happen, leaving you unprotected against, for example, a heart attack or stroke.
- Risk of Side Effects: In the case of delayed breakdown of active medication, the concentration of the substance in your bloodstream rises. This can lead to toxicity and serious side effects, even with a ‘normal’ dose.
- Insufficient Levels: With an overactive enzyme (ultrarapid), your body breaks down the medication so quickly that a high enough level is never reached in the blood to be effective.
Medications where CYP2C19 plays a role
The following groups of medication are primarily processed via the CYP2C19 pathway. A pharmacogenetic passport provides essential guidance in this regard:
- Blood thinners: including Clopidogrel (Plavix).
- Proton pump inhibitors (PPIs): including Omeprazole, Pantoprazole, Lansoprazole.
- Antidepressants (SSRIs/TCAs): including Citalopram, Escitalopram, Sertraline, Amitriptyline.
- Antiepileptics: including Phenytoin.
- Anxiolytics: including Diazepam.
Interpretation of your CYP2C19 status
Based on your genetic results, you will be classified into one of four metabolism types. This determines how your body responds to the medications mentioned above:
| Result | Interpretatie | Interpretation |
|---|---|---|
| PM | Poor Metabolizer (Non-expressor) | The enzyme is inactive. This is the case for most Europeans. You have an increased risk of side effects with standard doses of specific medications. |
| IM | Intermediate Metabolizer | The enzyme exhibits limited activity. Medication processing is slower than average, often requiring careful dosing. |
| NM | Normal Metabolizer (Expressor) | The enzyme is active and functioning normally. Certain medications (such as tacrolimus) are broken down more quickly, so a higher dose is often required for effectiveness. |
| UM | Ultrarapid Metabolizer | The enzyme works extremely quickly. Medication is removed from the body very quickly, which increases the risk of insufficient effectiveness of the therapy. |
Medical interpretation & advice
The results of your test at Easly are benchmarked against the official medication guidelines of the KNMP (G-Standaard). This provides you, your pharmacist, and your doctor with a scientific foundation for a tailored treatment.
Important: Always use this result in consultation with your treating physician or pharmacist. Never adjust your dosage independently. Based on your profile, a doctor or pharmacist may decide to optimize the dose or switch to a medication that does not depend on this specific enzyme.
Stop living with unexplained side effects.
Do you want to know if your symptoms can be explained by your DNA profile? Take the free Pharmacogenetic Quickscan (available in Dutch only) and get immediate clarity on whether a test is useful for you.
